Skip to search.
 TSX Up 0.40% TSX Ventures Down 1.68%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
396.22 Up 2.68(0.68%) May 27, 4:00PM EDT
|After Hours : 396.22 0.00 (0.00%) May 27, 5:11PM EDT
Prev Close:393.54
Open:395.39
Bid:389.00 x 200
Ask:414.00 x 100
1y Target Est:473.48
Beta:1.50334
Earnings Date:Aug 2 - Aug 8 (Est.)
Day's Range:389.62 - 398.49
52wk Range:348.96 - 605.93
Volume:548,059
Avg Vol (3m):969,380
Market Cap:41.42B
P/E (ttm):62.82
EPS (ttm):6.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 0.68%41.42B
AMGNUp 0.77%117.75B

Key Statistics

Forward P/E (1 yr):24.95
P/S (ttm):9.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :10.98
Quarterly EPS Est (Jun-16) :2.65
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.91

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback